Common Contracts
15 similar Executive Severance Benefits Agreement contracts by Sunesis Pharmaceuticals Inc
EX-10.6 6 snss-ex106_330.htm EX-10.6 THIRD AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • May 5th, 2020 • California
This Third Amended and Restated Executive Severance Benefits Agreement (the “Agreement”) is entered into this 13th day of April, 2016 (the “Effective Date”), between Daniel N. Swisher, Jr. (“Executive”) and Sunesis Pharmaceuticals, Inc. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 6.
THIRD AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • May 9th, 2016 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This Third Amended and Restated Executive Severance Benefits Agreement (the “Agreement”) is entered into this 13th day of April, 2016 (the “Effective Date”), between Daniel N. Swisher, Jr. (“Executive”) and Sunesis Pharmaceuticals, Inc. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 6.
THIRD AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • May 9th, 2016 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This Third Amended and Restated Executive Severance Benefits Agreement (the “Agreement”) is entered into this 13th day of April, 2016 (the “Effective Date”), between Eric H. Bjerkholt (“Executive”) and Sunesis Pharmaceuticals, Inc. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 6.
SECOND AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • April 3rd, 2009 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This Second Amended and Restated Executive Severance Benefits Agreement (the “Agreement”) is entered into this 24th day of December, 2008 (the “Effective Date”), between Daniel n. Swisher, Jr. (“Executive”) and Sunesis Pharmaceuticals, Inc. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 6.
SECOND AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • April 3rd, 2009 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This Second Amended and Restated Executive Severance Benefits Agreement (the “Agreement”) is entered into this 24th day of December, 2008 (the “Effective Date”), between Valerie L. Pierce (“Executive”) and Sunesis Pharmaceuticals, Inc. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 6.
SECOND AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • April 3rd, 2009 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This Second Amended and Restated Executive Severance Benefits Agreement (the “Agreement”) is entered into this 24th day of December, 2008 (the “Effective Date”), between Eric H. Bjerkholt (“Executive”) and Sunesis Pharmaceuticals, Inc. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 6.
AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • April 3rd, 2009 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This Amended and Restated Executive Severance Benefits Agreement (the “Agreement”) is entered into this 23rd day of December, 2008 (the “Effective Date”), between Steve Ketchum (“Executive”) and Sunesis Pharmaceuticals, Inc. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 6.
SECOND AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • April 3rd, 2009 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This Second Amended and Restated Executive Severance Benefits Agreement (the “Agreement”) is entered into this 23rd day of December, 2008 (the “Effective Date”), between James W. Young (“Executive”) and Sunesis Pharmaceuticals, Inc. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 6.
AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • August 7th, 2008 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENT(the “Agreement”) is entered into this 26th day of May, 2008 (the “Effective Date”), between JAMES W. YOUNG, PH.D (“Executive”) and SUNESIS PHARMACEUTICALS, INC. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 6.
AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • August 7th, 2008 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This Amended and Restated Executive Severance Benefits Agreement (the “Agreement”) is entered into this 28th day of May, 2008 (the “Effective Date”), between Daniel N. Swisher, Jr. (“Executive”) and Sunesis Pharmaceuticals, Inc. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 6.
EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • August 7th, 2008 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This EXECUTIVE SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this second day of June, 2008 (the “Effective Date”), between STEVE KETCHUM (“Executive”) and SUNESIS PHARMACEUTICALS, INC. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 6.
AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • August 7th, 2008 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This Amended and Restated Executive Severance Benefits Agreement (the “Agreement”) is entered into this 27th day of May, 2008 (the “Effective Date”), between Daniel C. Adelman, M.D. (“Executive”) and Sunesis Pharmaceuticals, Inc. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 6.
AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • August 7th, 2008 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This Amended and Restated Executive Severance Benefits Agreement (the “Agreement”) is entered into this 28th day of May, 2008 (the “Effective Date”), between Robert McDowell, Ph.D. (“Executive”) and Sunesis Pharmaceuticals, Inc. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 6.
AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • August 7th, 2008 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this 22nd day of May, 2008 (the “Effective Date”), between VALERIE L. PIERCE (“Executive”) and SUNESIS PHARMACEUTICALS, INC. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 6.
AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • August 7th, 2008 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this 29th day of May, 2008 (the “Effective Date”), between ERIC H. BJERKHOLT(“Executive”) and SUNESIS PHARMACEUTICALS, INC. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 6.
